January 26, 2026

Need a cheaper, more accessible OCD treatment? There’s an app for that

January 26, 2026 / Clinical Practice / InnovateMed Author / OCD treatment

by Christina Pazzanese, Harvard Gazette edited by Lisa Lock, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Sabine Wilhelm. Credit: Stephanie Mitchell/Harvard Staff Photographer Those who experience the paralyzing psychological and social effects of obsessive-compulsive disorder can often find relief in cognitive behavioral therapy, or CBT. But not everyone who may benefit from […]

Need a cheaper, more accessible OCD treatment? There’s an app for that Read More »

Unique compound from Korean ginseng shows promising effects against hair loss

January 26, 2026 / Research update / InnovateMed Author / hair loss, Korean ginseng

by Sejong University edited by Sadie Harley, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Graphical abstract. Credit: Industrial Crops and Products (2026). DOI: 10.1016/j.indcrop.2026.122686 A research team led by Professor Tae-Gyu Lim from the Department of Food Science and Biotechnology at Sejong University has published a study that scientifically demonstrates the hair growth-promoting and anti-androgenetic

Unique compound from Korean ginseng shows promising effects against hair loss Read More »

Antibodies targeting IgE Cε2 domain show promise for rapid allergy relief

January 26, 2026 / Research update / InnovateMed Author / allergy relief, antibodies

by Juntendo University edited by Sadie Harley, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Researchers identify antibody fragments capable of removing immunoglobulin E bound to mast cells, revealing a potentially fast-acting therapy for severe allergic diseases. Credit: Tomoaki Ando of Juntendo University Allergic diseases represent a major global health burden, placing significant strain

Antibodies targeting IgE Cε2 domain show promise for rapid allergy relief Read More »

Blepharitis Comprehensive information for you or a loved one

January 26, 2026 / Patient education / InnovateMed Author / blepharitis

Comprehensive information for you or a loved one — including treatment options and discounts on popular medications. Written by Patricia Pinto-Garcia, MD, MPH | Reviewed by Nishika Reddy, MD Published on February 6, 2024 Definition Blepharitis is an inflammatory eye condition that affects the eyelid edge. Your eyelid ridge (or eyelid margin) is made up of skin, tiny oil glands,

Blepharitis Comprehensive information for you or a loved one Read More »

New role for GLP-1 drugs: Improving survival in people with severe psychiatric disorders

January 26, 2026 / Research update / InnovateMed Author / psychiatric disorder

By Tarun Sai LomteReviewed by Susha Cheriyedath, M.Sc.Jan 25 2026 An expert editorial suggests that widely used diabetes and obesity drugs may help close the long-standing mortality gap faced by people with serious mental illnesses by tackling cardiovascular risk and metabolic disease head-on. Editorial: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have potential to transform health outcomes for persons

New role for GLP-1 drugs: Improving survival in people with severe psychiatric disorders Read More »

Big Pharma Skips the Hype: AI Already Cutting Drug Trial Times by Months

January 26, 2026 / Clinical Practice / InnovateMed Author / drug trial

The pharmaceutical industry’s AI revolution isn’t arriving through miracle molecule discovery. It’s sneaking in through paperwork. While tech headlines obsess over AI designing breakthrough drugs from scratch, pharmaceutical executives gathered at the recent JP Morgan Healthcare Conference revealed a different story. The real gains? Automating the mountain of administrative tasks that make drug development so painfully slow

Big Pharma Skips the Hype: AI Already Cutting Drug Trial Times by Months Read More »

Lithium study yields insights in the fight against HIV

January 26, 2026 / Research update / InnovateMed Author / lithium

Lithium, a widely used treatment for bipolar disorder and other mood disorders, has shown early promise in suppressing HIV, McGill University researchers report. Scanning electron micrograph of an HIV-infected H9 T cell, colorized in Halloween colors. Image credit: NIAID A new study published in iScience found lithium can prevent infected cells from reactivating, and that it does

Lithium study yields insights in the fight against HIV Read More »

Bringing Optical Color to Ultrasound

January 26, 2026 / Clinical Practice / InnovateMed Author / optical color

Through a clever combination of two imaging modalities, scientists from Caltech and USC have developed a new technique that can quickly provide 3D color images that capture both the structure of soft tissues and details of how the blood vessels are functioning. The researchers have used the new technique to successfully image multiple parts of

Bringing Optical Color to Ultrasound Read More »

Japanese version of rPATD validated to assess attitudes toward medication reductions among patients and caregivers

January 26, 2026 / Clinical Practice / InnovateMed Author / medication

Peer-Reviewed Publication University of Tsukuba Tsukuba, Japan—Older adults have an increased risk of adverse drug reactions and medication errors due to the greater number of prescriptions they frequently require to address multiple chronic conditions. The issue of polypharmacy is particularly pressing in Japan, and the promotion of appropriate medication reduction is a national priority. However,

Japanese version of rPATD validated to assess attitudes toward medication reductions among patients and caregivers Read More »

Optimized solvent design improves lymphatic drug delivery to metastatic lymph nodes

January 26, 2026 / Research update / InnovateMed Author / lymph nodes

Peer-Reviewed Publication Tohoku University image: Overview of Lymphatic Drug Delivery Systems (LDDS) and the Optimal Ranges of Solvent Osmolarity and Viscosity Depending on Therapeutic Strategies. view more Credit: Taiki Shimano et al. Optimizing drug delivery to the lymphatic system is essential for effective cancer treatment, as lymph node (LN) metastasis is a critical factor influencing patient

Optimized solvent design improves lymphatic drug delivery to metastatic lymph nodes Read More »